Blog
RSS FeedPosted by Michael Wonder on 04 Apr 2020
Alternative drug purchasing arrangements do not justify raising the prices Medicaid pays for brand drugs
3 April 2020 - As the prescription drug pipeline fills with very high-cost gene therapies and specialty drugs, affordability and access ...
Posted by Michael Wonder on 31 Mar 2020
1 April 2020 price disclosure confirmed prices
31 March 2020 - Confirmed 1 April 2020 prices resulting from the 2020 April cycle of price disclosure have been published ...
Posted by Michael Wonder on 24 Mar 2020
National health expenditure projections, 2019–28: expected rebound in prices drives rising spending growth
24 March 2020 - US national health expenditures are projected to grow at an average annual rate of 5.4% for ...
Posted by Michael Wonder on 23 Mar 2020
Intra-Cellular prices schizophrenia drug at $1,320 per month
23 March 2020 - Intra-Cellular Therapies said on Monday its lead drug to treat schizophrenia was now available at U.S. ...
Posted by Michael Wonder on 23 Mar 2020
Determinants of orphan drug prices in Germany
21 March 2020 - Legislation introduced in 2011 in Germany has instituted an early benefit assessment of newly licensed pharmaceuticals with ...
Posted by Michael Wonder on 21 Mar 2020
U.S. pharma that makes potential coronavirus drug touted by Donald Trump doubled price to $19.88 a pill
20 March 2020 - Company calls hike in January during China outbreak coincidental and said it restored old price. ...
Posted by Michael Wonder on 19 Mar 2020
Low prices won't keep new medicines out of Canada
19 March 2020 - There is no evidence of a link between pricing, research and development, and access to medicine. ...
Posted by Michael Wonder on 17 Mar 2020
Erlotinib new exchange groups
13 March 2020 - As of April, erlotinib is included as an exchange group on the list of goods for ...
Posted by Michael Wonder on 15 Mar 2020
Mending the broken social contract for pharmaceutical pricing and innovation
13 March 2020 - The biopharmaceutical industry is under unprecedented assault by the public and politicians. ...
Posted by Michael Wonder on 10 Mar 2020
White House principles for reducing drug costs
10 March 2020 - In our partisan times, an opportunity for lawmakers to work across the aisle and get something done. ...
Posted by Michael Wonder on 08 Mar 2020
Price controls imposed by shortsighted politicians keep new life-saving drugs out
5 March 2020 - Politicians need to step outside the Ottawa bubble and understand how their policies impact the lives of ...
Posted by Michael Wonder on 05 Mar 2020
The U.S. has a problem with prescription drug prices. Canada shouldn’t try to fix it.
2 March 2020 - President Donald Trump and the U.S. Congress are scrambling to find ways to make medicines more ...
Posted by Michael Wonder on 04 Mar 2020
Sanofi, fighting back in insulin price debate, says its net prices fell 11%
4 March 2020 - Politicians have called price increases egregious, while large insulin makers have become prime targets for criticism in ...
Posted by Michael Wonder on 04 Mar 2020
Drug shortages in the United States. Are some prices too low?
3 March 2020 - The US public identified lowering prescription drug prices as the top health priority for Congress in 2019. ...
Posted by Michael Wonder on 04 Mar 2020
Changes in list prices, net prices, and discounts for branded drugs in the US, 2007-2018
3 March 2020 - Using 2007-2018 net pricing data on branded pharmaceutical products in the US, list prices increased by 159% ...